Pharmacogenetics testing (DPYD and UGT1A1) for fluoropyrimidine and irinotecan in routine clinical care: Perspectives of medical oncologists and oncology pharmacists
- Creator: Glewis, Sarah , Lingaratnam, Senthil , Krishnasamy, Michael , Martin, Jennifer H. , Tie, Jeanne , Alexander, Marliese , Michael, Michael
- Resource Type: journal article
- Date: 2024
Pharmacogenetics of cyclophosphamide and CYP2C19 polymorphism in Thai systemic lupus erythematosus
- Creator: Ngamjanyaporn, Pintip , Thakkinstian, Ammarin , Verasertniyom, Oravan , Chatchaipun, Porntip , Vanichapuntu, Monchand , Nantiruj, Kanokrat , Totemchokchyakarn, Kitti , Attia, John , Janwityanujit, Suchela
- Resource Type: journal article
- Date: 2011
The risk of coronary thrombosis with cyclo-oxygenase-2 inhibitors does not vary with polymorphisms in two regions of the cyclo-oxygenase-2 gene
- Creator: McGettigan, Patricia , Lincz, Lisa F. , Henry, David , Attia, John , McElduff, Patrick , Bissett, Linda , Peel, Roseanne , Stokes, Barrie , Hancock, Stephen , Henderson, Kim , Seldon, Michael
- Resource Type: journal article
- Date: 2011
Long-term efficacy of oral deferiprone in management of iron overload in beta thalassemia major
- Creator: Goel, Himanshu , Girisha, K. M. , Phadke, Shubha
- Resource Type: journal article
- Date: 2008